GE HealthCare Technologies Inc (GEHC) is a publicly traded company listed on the Large. It operates in the Medical Devices industry, part of the broader Healthcare sector. The company has a market capitalization of 29.65B, generates annual revenue of 20.98B, and reports net income of 1.91B. As of the latest data, the stock is trading at 65.18 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (0.17%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.96), indicating current market sentiment. Institutional ownership is reported at 88.23%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -10.85%, trading within a 52-week range of 58.75 - 89.77.
| Index: | NDX, S&P 500 | P/E: | 15.60 | EPS (ttm): | 4.18 | Insider Own: | 0.30% | Shs Outstand: | 454.89M | Perf Week: | 0.79% |
| Market Cap: | 29.65B | Forward P/E: | 12.07 | EPS next Y: | 5.40 | Insider Trans: | 8.22% | Shs Float: | 453.54M | Perf Month: | 5.32% |
| Income(ttm): | 1.91B | PEG: | 1.28 | EPS next Q: | 1.03 | Inst Own: | 88.23% | Short Float: | 3.23% | Perf Quarter: | -7.90% |
| Revenue(ttm): | 20.98B | P/S: | 1.41 | EPS this Y: | 6.28% | Inst Trans: | -1.86% | Short Ratio: | 3.03 | Perf Half Y: | -22.84% |
| Book/sh: | 23.45 | P/B: | 2.78 | EPS next Y: | 10.69% | ROA: | 5.40% | Short Interest: | 14.67M | Perf Year: | -10.85% |
| Cash/sh: | 5.02 | P/C: | 12.98 | EPS next 5Y: | 9.45% | ROE: | 19.24% | 52W Range: | 58.75 - 89.77 | Perf YTD: | -20.53% |
| Dividend Est.: | 0.11 (0.17%) | P/FCF: | 19.52 | EPS past 3/5Y: | 2.53% 0.61% | ROIC: | 9.05% | 52W High: | 89.77 -27.39% | Beta: | 0.81 |
| Dividend TTM: | 0.14 (0.21%) | Quick Ratio: | 0.89 | Sales past 3/5Y: | 3.99% 3.74% | Gross Margin: | 38.84% | 52W Low: | 58.75 10.94% | Perf 5Y: | - |
| Dividend Ex-Date: | Apr 02, 2026 | Current Ratio: | 1.17 | EPS Y/Y TTM: | -12.36% | Oper. Margin: | 13.38% | RSI (14): | 53.62 | Volatility: | 2.76% 2.71% |
| Employees: | 54000 | Debt/Eq: | 0.99 | Sales Y/Y TTM: | 5.97% | Profit Margin: | 9.10% | Recom: | 1.62 | Target Price: | 78.62 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.98 | EPS Q/Q: | -30.73% | Payout: | 3.08% | Rel Volume: | 0.66 | Prev Close: | 64.51 |
| Sales Surprise: | 1.76% | EPS Surprise: | -5.25% | Sales Q/Q: | 7.41% | Earnings: | Apr 29 BMO | Avg Volume: | 4.84M | Price: | 65.18 |
| SMA20: | 2.71% | SMA50: | -1.34% | SMA200: | -12.93% | Undervalued: 20.62% | Volume: | 3,174,462 | Change: | 1.04% | |
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.